Clinical Cancer Research Versailles No Abst Advances in Breast Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mohanam, S.
Right arrow Articles by Rao, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mohanam, S.
Right arrow Articles by Rao, J. S.
Clinical Cancer Research Vol. 7, 2519-2526, August 2001
© 2001 American Association for Cancer Research


Regular Articles

Stable Transfection of Urokinase-Type Plasminogen Activator Antisense Construct Modulates Invasion of Human Glioblastoma Cells1

Sanjeeva Mohanam, Sushma L. Jasti, Sudha R. Kondraganti, Nirmala Chandrasekar, Yoshiaki Kin, Gregory N. Fuller, Sajani S. Lakka, Athanassios P. Kyritsis, Dzung H. Dinh, William C. Olivero, Meena Gujrati, W. K. A. Yung and Jasti S. Rao2

Division of Cancer Biology, Department of Biomedical and Therapeutic Sciences [S. M., N. C., S. S. L., J. S. R.] and Departments of Neurosurgery [D. H. D., W. C. O., J. S. R.] and Pathology [M. G.], University of Illinois College of Medicine at Peoria, Peoria, Illinois 61656, and Departments of Neurosurgery [S. R. K., Y. K.], Neuro-Oncology [S. L. J., A. P. K., W. K. A. Y.], and Neuropathology [G. N. F.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

The diffuse and extensive infiltration of malignant gliomas into the surrounding normal brain is believed to rely on modifications of the proteolysis of extracellular matrix components. A key molecule in regulating plasminogen-mediated extracellular proteolysis is the urokinase-type plasminogen activator (uPA). To investigate the role of uPA in the invasive process of brain tumors, we stably transfected a human glioblastoma cell line SNB19 with a vector capable of expressing an antisense transcript complementary to the 1020 bases at the 3' end of the uPA cDNA. Parental, vector-, and antisense construct-stably transfected cell lines were analyzed for uPA mRNA transcript by Northern blot analysis, for uPA enzyme activity by zymography, and for uPA protein levels by Western blotting. The levels of uPA mRNA, protein, and enzyme activities were significantly lower in antisense clones than in parental and vector controls. Radioreceptor binding studies demonstrated that uPA receptor levels remained the same in parental, vector-, and antisense-transfected cells. The antisense-transfected cells showed a markedly lower level of invasion in the Matrigel invasion assays, and their spheroids failed to invade the fetal rat brain aggregates in the coculture system. Green fluorescent protein (GFP) expressing parental and antisense transfectants was generated for detection in mouse brain tissue without any posttreatment. Intracerebral injection of antisense stable transfectants significantly reduced tumor formation compared with that in controls. Our results suggested that down-regulation of uPA expression may be a feasible approach to reducing the malignancy and invasiveness of glial tumors.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
A. P. Mazar
Urokinase Plasminogen Activator Receptor Choreographs Multiple Ligand Interactions: Implications for Tumor Progression and Therapy
Clin. Cancer Res., September 15, 2008; 14(18): 5649 - 5655.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. S. Gondi, S. S. Lakka, D. H. Dinh, W. C. Olivero, M. Gujrati, and J. S. Rao
Intraperitoneal Injection of a Hairpin RNA Expressing Plasmid Targeting Urokinase-Type Plasminogen Activator (uPA) Receptor and uPA Retards Angiogenesis and Inhibits Intracranial Tumor Growth in Nude Mice
Clin. Cancer Res., July 15, 2007; 13(14): 4051 - 4060.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. R. Merchan, J. Tang, G. Hu, Y. Lin, W. Mutter, C. Tong, S. A. Karumanchi, S. J. Russell, and V. P. Sukhatme
Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
J Natl Cancer Inst, June 7, 2006; 98(11): 756 - 764.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Suzuki, H. Kobayashi, N. Kanayama, Y. Saga, M. Suzuki, C.-Y. Lin, R. B. Dickson, and T. Terao
Inhibition of Tumor Invasion by Genomic Down-regulation of Matriptase through Suppression of Activation of Receptor-bound Pro-urokinase
J. Biol. Chem., April 9, 2004; 279(15): 14899 - 14908.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. M. Le, A. Besson, D. K. Fogg, K.-S. Choi, D. M. Waisman, C. G. Goodyer, B. Rewcastle, and V. W. Yong
Exploitation of Astrocytes by Glioma Cells to Facilitate Invasiveness: A Mechanism Involving Matrix Metalloproteinase-2 and the Urokinase-Type Plasminogen Activator-Plasmin Cascade
J. Neurosci., May 15, 2003; 23(10): 4034 - 4043.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.